Tilray Inc (TLRY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $345.82M
Last updated: Nov 17, 2026 at 4:43 PM ET
Tilray Inc (TLRY) Statistics
Tilray (TLRY) has a market cap of $345.82M and an enterprise value of $332.28M. Its share count is up 25.76% from a year earlier. It kept -17.05% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 3.92% below the market cap, as cash exceeds debt.
| Market Cap | $345.82M |
|---|---|
| Enterprise Value | $332.28M |
| Latest price (Nov 17, 2026) | $2.35 |
Key Dates
The next earnings report is expected on Jan 6, 2027, covering the quarter ending Nov 30, 2026.
| Next Earnings Date | Jan 6, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 8, 2026 |
| Fiscal Year End | May |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.2x.
| P/S Ratio | 0.3x |
|---|---|
| Forward P/S | 0.3x |
| P/B Ratio | 0.2x |
| P/TBV Ratio | 0.4x |
Price Statistics
The stock is down 78.24% over 52 weeks and trades 29.22% below its 50-day average.
| Beta (1Y) | 1.37 |
|---|---|
| 52-Week Change | -78.24% |
| 1-Month Change | -22.44% |
| 3-Month Change | -51.35% |
| 6-Month Change | -54.89% |
| 5-Year Change | -97.54% |
| Total Return (1Y) | -78.24% |
| Total Return (3Y CAGR) | -49.54% |
| Total Return (5Y CAGR) | -53.60% |
| Return vs SPY (1Y) | -88.74% |
| Max Drawdown (1Y) | -83.21% |
| Max Drawdown (3Y) | -91.79% |
| Sharpe Ratio (1Y) | -1.92 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $3.32 |
| 200-Day Average | $5.12 |
| 52-Week Range | $2.33 to $15.70 |
| RSI (14 Days) | 29.2 |
| Average Volume (20 Days) | 4.96M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.88x current liabilities, and total debt is 0.12x shareholder equity.
| Current Ratio | 1.88x |
|---|---|
| Quick Ratio | 1.11x |
| Debt / Equity | 0.12x |
| Interest Coverage | -3.80x |
Returns and Efficiency
Return on invested capital is -4.89% over the last 12 months, against a 5-year average of -34.29%.
| Return on Equity (ROE) | -10.12% |
|---|---|
| Return on Assets (ROA) | -7.05% |
| Return on Invested Capital (ROIC) | -4.89% |
| Return on Capital Employed (ROCE) | -4.70% |
| ROE (5Y Average) | -43.62% |
| ROA (5Y Average) | -31.79% |
| ROIC (5Y Average) | -34.29% |
| Asset Turnover | 0.44x |
| Inventory Turnover | 2.19x |
| Receivables Turnover | 5.07x |
| Cash Conversion Cycle | 66 days |
Scores
TLRY has an Altman Z-Score of -2.27, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -2.27 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $963.10M over the last 12 months is up 15.93% from the 12 months before.
| Revenue | $963.10M |
|---|---|
| Revenue Growth (YoY) | +15.93% |
| Gross Profit | $274.29M |
| Operating Income | -$77.21M |
| Pretax Income | -$125.59M |
| Net Income | -$164.22M |
| EBITDA | -$18.52M |
| EBIT | -$89.20M |
| Reported EPS (TTM) | -$0.75 |
Trailing 12 months through Aug 31, 2026.
Balance Sheet
Shareholder equity funds 69.53% of the $2.33B in total assets.
| Cash and Equivalents | $214.96M |
|---|---|
| Total Debt | $201.41M |
| Net Cash | $13.54M |
| Net Cash Per Share | $0.10 |
| Working Capital | $376.90M |
| Shareholder Equity | $1.62B |
| Book Value Per Share | $12.17 |
| Tangible Book Value | $828.54M |
| Tangible Book Per Share | $6.21 |
| Total Assets | $2.33B |
| Total Liabilities | $721.28M |
Balance sheet as of Aug 31, 2026.
Cash Flow
After $34.51M of capital spending, operating cash flow left -$119.00M of free cash flow.
| Operating Cash Flow | -$84.49M |
|---|---|
| Capital Expenditures | $34.51M |
| Free Cash Flow | -$119.00M |
| FCF Per Share | -$0.81 |
| Depreciation and Amortization | $70.68M |
Trailing 12 months through Aug 31, 2026.
Margins
The operating margin is -8.02%.
| Gross Margin | 28.48% |
|---|---|
| Operating Margin | -8.02% |
| Pretax Margin | -13.04% |
| Net Margin | -17.05% |
| EBITDA Margin | -1.92% |
| EBIT Margin | -9.26% |
| FCF Margin | -12.36% |
| Gross Margin (5Y Average) | 25.62% |
Growth
Revenue grew 13.44% a year over 3 years.
| Revenue Growth (3Y CAGR) | +13.44% |
|---|---|
| Revenue Growth (5Y CAGR) | +12.28% |
| Book Value Per Share Growth (2Y CAGR) | -41.54% |
| Tangible Book Per Share Growth (2Y CAGR) | +7.30% |
Dividends and Yields
TLRY does not pay a dividend. Its free cash flow yield is -37.98%.
| FCF Yield | -37.98% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-10 reverse split on Dec 2, 2025.
| Last Split Date | Dec 2, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 8 similar companies, TLRY has the lowest P/S.
P/S RatioPeer median 1.9x
ROICPeer median -16.60%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.87%
| P/S Ratio | 0.3x vs 1.9x median |
|---|---|
| ROIC | -4.89% vs -16.60% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +15.93% vs +13.87% median |
Analyst Forecast
Consensus estimates put revenue growth at 12.47% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +12.47% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About TLRY
What is TLRY's market cap?
Tilray has a market cap of $345.82M. Its enterprise value, which adds debt and subtracts cash, is $332.28M.
How many shares of TLRY are outstanding?
Tilray has 133.34M shares outstanding. The count is up 25.76% from a year earlier.
Does TLRY pay a dividend?
No. Tilray does not pay a dividend.
How much debt does TLRY have?
Tilray has $201.41M of total debt and $214.96M of cash and equivalents, a net cash position of $13.54M.
TLRY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors